Zobrazeno 1 - 10
of 17
pro vyhledávání: '"R. Levai"'
Autor:
Heinrich Haas, R. Levai, Roger Le Grand, Yoann Aldon, Annette B. Vogel, Robin J. Shattock, Ugur Sahin, Katalin Fábián, Nathalie Dereuddre-Bosquet, Jorge Moreno Herrero, Paul F. McKay, Pauline Maisonnasse
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 25, Iss, Pp 483-493 (2021)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Self-amplifying mRNA (saRNA) represents a promising platform for nucleic acid delivery of vaccine immunogens. Unlike plasmid DNA, saRNA does not require entry into the nucleus of target cells for expression, having the capacity to drive higher protei
Autor:
Dietmar Katinger, Robin J. Shattock, Edith E. Schermer, Judith A. Burger, Philipp Mundsperger, Philip J. M. Brouwer, R. Levai, Monica Tolazzi, Rogier W. Sanders, John P. Moore, Quentin J. Sattentau, Ilja Bontjer, Kwinten Sliepen, Attila Farsang, Gabriella Scarlatti
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 6, Iss 1, Pp 1-1 (2021)
npj Vaccines, Vol 6, Iss 1, Pp 1-1 (2021)
The immunogenicity of HIV-1 envelope (Env) trimers is generally poor. We used the clinically relevant ConM SOSIP trimer to compare the ability of different adjuvants (squalene emulsion, ISCOMATRIX, GLA-LSQ, and MPLA liposomes) to support neutralizing
Autor:
Rogier W. Sanders, Quentin J. Sattentau, Attila Farsang, Ilja Bontjer, Gabriella Scarlatti, Dietmar Katinger, R. Levai, John P. Moore, Robin J. Shattock, Philip J. M. Brouwer, Kwinten Sliepen, Edith E. Schermer, Monica Tolazzi, Judith A. Burger, Philipp Mundsperger
Publikováno v:
NPJ Vaccines
npj Vaccines, 6(1):103. Nature Publishing Group
npj Vaccines, Vol 6, Iss 1, Pp 1-8 (2021)
npj Vaccines
npj Vaccines, 6(1):103. Nature Publishing Group
npj Vaccines, Vol 6, Iss 1, Pp 1-8 (2021)
npj Vaccines
The immunogenicity of HIV-1 envelope (Env) trimers is generally poor. We used the clinically relevant ConM SOSIP trimer to compare the ability of different adjuvants (squalene emulsion, ISCOMATRIX, GLA-LSQ, and MPLA liposomes) to support neutralizing
Autor:
Katalin Fábián, T. Barna, Sandra Blome, G. Kulcsár, Attila Farsang, R. Levai, K. Belák, Frank Koenen, Ádám Bálint
Publikováno v:
Biologicals. 43:92-99
Classical swine fever (CSF) marker vaccine candidate CP7_E2alf produced under Good Laboratory Practice (GLP) conditions by Pfizer was tested on 40 six-week-old MDA-piglets according to the European Pharmacopoeia (Ph.Eur.) requirements. Single doses o
Autor:
R. Levai, G. Kulcsár, M. Le Dimna, Frank Koenen, Claudia Gabriel, M.F. Le Potier, Sandra Blome, Patricia Renson
Publikováno v:
Research in Veterinary Science. 96:389-395
CP7_E2alf is a promising marker vaccine candidate against classical swine fever (CSF). To better understand the mechanisms of protection, cytokine and isotype-specific antibody profiles were investigated in CP7_E2alf vaccinated pigs before and after
Autor:
T. Barna, G. Kulcsár, Marylène Tignon, K. Belák, Yves Van der Stede, Attila Farsang, R. Levai, Robert Vrancken, Katalin Fábián, Andy Haegeman, Frank Koenen
Publikováno v:
Veterinary Microbiology. 142:59-68
Effective oronasal vaccination against classical swine fever (CSF) is essential to achieve protection in wild boar. However the currently available live CSF vaccines, e.g. C-strain, do not allow serological differentiation between infected and vaccin
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R, Levai
Publikováno v:
Medical economics. 77(7)
The two-proton correlation function at midrapidity from Pb + Pb central collisions at 158 A GeV has been measured by the NA49 experiment. The results are compared to model predictions from static thermal Gaussian proton source distributions and trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::803db8b972da664e795536dab5cf9a99
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3052454
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3052454
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.